National Coverage Determinations

section notes

190 : Pathology and Laboratory

section notes
Document(s) Description
190.1  Histocompatibility Testing
190.2  Diagnostic Pap Smears
190.3  Cytogenetic Studies
190.4  Electron Microscope - RETIRED
190.5  Sweat Test
190.6  Hair Analysis
190.7  Human Tumor Stem Cell Drug Sensitivity Assays
190.8  Lymphocyte Mitogen Response Assays
190.9  Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS)
190.10  Laboratory Tests - CRD Patients
190.11  Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management
190.12  Urine Culture, Bacterial
190.13  Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)
190.14  Human Immunodeficiency Virus (HIV) Testing (Diagnosis)
190.15  Blood Counts
190.16  Partial ThromboplastinTime (PTT)
190.17  Prothrombin Time (PT)
190.18  Serum Iron Studies
190.19  Collagen Crosslinks, any Method
190.20  Blood Glucose Testing
190.21  Glycated Hemoglobin/Glycated Protein
190.22  Thyroid Testing
190.23  Lipid Testing
190.24  Digoxin Therapeutic Drug Assay
190.25  Alpha-fetoprotein
190.26  Carcinoembryonic Antigen
190.27  Human Chorionic Gonadotropin
190.28  Tumor Antigen by Immunoassay - CA 125
190.29  Tumor Antigen by Immunoassay - CA 15-3/CA 27.29
190.30  Tumor Antigen by Immunoassay - CA 19-9
190.31  Prostate Specific Antigen
190.32  Gamma Glutamyl Transferase
190.33  Hepatitis Panel/Acute Hepatitis Panel
190.34  Fecal Occult Blood Test
free demo
request yours today
pricing
for any budget
sign IN
welcome back!